CD274 and breast carcinoma: Therefore, reducing the expression of PD-L1 and/or decreasing its combination with PD-1 allows T cells to function normally, which plays an important role in the treatment of breast cancer by inhibiting the progression of precancerous lesions to malignant carcinoma.